Challenges of treatment adherence with direct oral anticoagulants in pandemic.

Publication

Challenges of treatment adherence with direct oral anticoagulants in pandemic.

Journal Paper/Review - Feb 1, 2021

Dittrich Tolga, Polymeris Alexandros A, De Marchis Gian Marco

Citation

Dittrich T, Polymeris A, De Marchis G. Challenges of treatment adherence with direct oral anticoagulants in pandemic. Curr Opin Neurol 2021; 34:38-44.

Type

Journal Paper/Review (English)

Journal

Curr Opin Neurol 2021; 34

Publication Date

Feb 1, 2021

Issn Electronic

1473-6551

Pages

38-44

Brief description/objective

Direct oral anticoagulants (DOAC) are crucial for the prevention of thromboembolic events in patients with nonvalvular atrial fibrillation. Drug adherence by the patient but also adherence to guidelines by the physician are suboptimal. This review highlights aspects of DOAC treatment during the coronavirus disease 2019 (COVID-19) pandemic and selected challenging scenarios.